LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 67.41 | 84.90 | 6760 | 8766 | 0.7711 | 0.9238 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.11 | 84.90 | 202 | 8988 | 0.0225 | 0.1376 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.11 | 84.90 | 5871 | 8988 | 0.6532 | 0.8773 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.11 | 84.90 | 412 | 8988 | 0.0458 | 0.2647 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 69.11 | 84.90 | 6985 | 8988 | 0.7772 | 0.9264 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.81 | 84.90 | 189 | 9132 | 0.0207 | 0.1259 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.81 | 84.90 | 6008 | 9132 | 0.6579 | 0.8797 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.81 | 84.90 | 358 | 9132 | 0.0392 | 0.2377 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.81 | 84.90 | 7126 | 9132 | 0.7803 | 0.9278 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.52 | 84.90 | 223 | 9214 | 0.0242 | 0.1535 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.52 | 84.90 | 6141 | 9214 | 0.6665 | 0.8835 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.52 | 84.90 | 324 | 9214 | 0.0352 | 0.2190 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.52 | 84.90 | 7290 | 9214 | 0.7912 | 0.9319 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 74.22 | 84.90 | 187 | 9343 | 0.0200 | 0.1235 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 74.22 | 84.90 | 6278 | 9343 | 0.6719 | 0.8861 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 74.22 | 84.90 | 376 | 9343 | 0.0402 | 0.2454 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 74.22 | 84.90 | 7485 | 9343 | 0.8011 | 0.9357 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 75.93 | 84.90 | 217 | 8970 | 0.0242 | 0.1498 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 75.93 | 84.90 | 6400 | 8970 | 0.7134 | 0.9020 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 75.93 | 84.90 | 400 | 8970 | 0.0446 | 0.2593 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 75.93 | 84.90 | 7630 | 8970 | 0.8506 | 0.9524 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 77.64 | 84.90 | 263 | 9245 | 0.0284 | 0.1819 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 77.64 | 84.90 | 6614 | 9245 | 0.7154 | 0.9034 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 77.64 | 84.90 | 376 | 9245 | 0.0407 | 0.2460 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 77.64 | 84.90 | 7790 | 9245 | 0.8426 | 0.9500 | MN20160318_Q02 | J17 |